Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC1A3 | P43003 | 3/20 | 0.44 |
| ▸ | SLC1A2 | P43004 | 3/20 | 0.44 |
| ▸ | SLC1A1 | P43005 | 3/20 | 0.44 |
| ▸ | CTSB | P07858 | 4/20 | 0.40 |
| ▸ | ACE | P12821 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.39 |
| ▸ | MAOB | P27338 | 1/20 | 0.39 |
| ▸ | LTA4H | P09960 | 1/20 | 0.39 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | PPARG | P37231 | 1/20 | 0.38 |
| ▸ | PPARA | Q07869 | 1/20 | 0.38 |
| ▸ | SRR | Q9GZT4 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7084380 | 0.88 | CTSB (0.40) | SLC1A3SLC1A2SLC1A1CTSBACE | |
| SCHEMBL24252159 | 0.85 | SMN1; SMN2 (0.39) | CYP1A2MEN1CYP2C9CYP2C19KMT2A | |
| SCHEMBL14282188 | 0.85 | CTSK (0.42) | CTSBCYP1A2ALOX5MEN1CYP2C9 | |
| SCHEMBL10686536 | 0.80 | CYP1A2 (0.43) | SLC1A3SLC1A2SLC1A1CYP1A2MEN1 | |
| SCHEMBL24252144 | 0.79 | ADAM17 (0.47) | — | |
| SCHEMBL27389520 | 0.79 | SLC1A3 (0.41) | SLC1A3SLC1A2SLC1A1CTSBCYP1A2 | |
| SCHEMBL10873777 | 0.78 | SLC1A1 (0.45) | SLC1A3SLC1A2SLC1A1CYP1A2MEN1 | |
| SCHEMBL16898172 | 0.77 | SMN1; SMN2 (0.41) | ACECYP1A2MEN1CYP2C9CYP2C19 | |
| SCHEMBL5268183 | 0.77 | ALDH1A1 (0.40) | SLC1A3SLC1A2SLC1A1CTSBCYP1A2 | |
| SCHEMBL27744904 | 0.77 | ALDH1A1 (0.40) | SLC1A3SLC1A2SLC1A1CTSBCYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230364272-A1 | THERANOSTIC COMPOUNDS | UNIVERSITY OF CAPE TOWN (ZA) | 2023-11-16 | — | — | US | disclosed |
| US-20230364272-A1 | THERANOSTIC COMPOUNDS | UNIVERSITY OF CAPE TOWN (ZA) | 2023-11-16 | — | — | US | disclosed |
| WO-2022034544-A1 | THERANOSTIC COMPOUNDS | NRF ITHEMBA LABS (ZA) | 2022-02-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230364272-A1 | THERANOSTIC COMPOUNDS | MMP12, TIMP3, CTSZ | SLC1A3 812/4885SLC1A2 948/4885SLC1A1 622/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.